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ABSTRACT 
 
BACKGROUND: Dry eye disease (DED) is a common, chronic ocular surface disease that 
diminishes the quality of life (QOL) of millions of Americans. DED is poorly managed because 
of the poor correlation of patient-reported symptom severity and clinician-observed disease 
severity. Our colleagues developed the UNC Dry Eye Management Scale (DEMS) in an effort 
to improve the management DED. The primary aim of this study was to translate the UNC 
DEMS to Spanish and to conduct a feasibility and comprehensibility study of a Spanish 
language version of the DEMS (Spanish DEMS) in a Spanish-speaking population. A 
secondary aim of our study was to perform initial validity and reliability testing of the Spanish 
DEMS, alone and as it compares to the original English instrument.  This study helps meet the 
urgent need for valid, reliable patient reported outcomes measures in languages other than 
English. 
METHODS:  We developed the Spanish DEMS by using a cross-cultural adaptation method 
similar to the universal translation methodology recommended by proponents of PROM 
translation. We recruited native bilingual speakers to perform forward, back, and forward 
translations. I then reconciled these different versions of the Spanish DEMS with the help of an 
expert translator, after which we put the Spanish DEMS through pre-testing and cognitive 
interviewing in a pilot sample population. After receiving approval from the UNC and Duke 
IRBs, I recruited 13 Spanish-speaking DED patients from a UNC ophthalmology cornea clinic 
in Chapel Hill, NC in May 2014 and June 2014 to participate in the first test of the Spanish 
DEMS.  I administered the Spanish DEMS questionnaire to these patients, and then using 
cognitive interviewing techniques, I asked them several questions about the comprehensibility 
of the questionnaire and its utility to them as an indicator of the effect of their symptoms on 
their quality of life.  I obtained clinical assessments of disease severity, (Schirmer’s test, Tear 
Break-Up Time, Oxford Grade of corneoconjunctival fluorescein staining, and clinician-reported 
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overall assessment of disease severity) to be used in statistical analysis of validity and 
reliability.  
RESULTS: Cognitive interviewing validated the accuracy and appropriateness of the 
translation. Patients generally understood, related to, and agreed with the wording of the 
questionnaire, including descriptions of symptom severity and effects on daily life. Analysis of 
validity and reliability is strictly illustrative, as sample size is too small for stable statistical data 
analysis (n=13). As a test of internal validity, I compared Spanish DEMS scores to these 
patients’ measures of disease severity. Spearman’s correlation coefficients showed non-
significant weak degrees of correlation, as expected given the fact that DED symptom severity 
does not correlate well with disease severity, and the sample was extremely small. While the 
magnitude of these correlations was not strong, the direction of the correlations was 
appropriate, and is promising for the further validation of the instrument. As a test of external 
validity, I compared performance on the Spanish language DEMS to performance on the 
English language instrument for patients of similar disease severity using the Mann-Whitney 
test. While performance on the two language versions was not statistically comparable within 
the overall population or for the normal disease category, it was significantly similar in the mild-
to-moderate and severe disease categories, which is promising for the equivalence of the two 
PROMs. This early validity and reliability testing, while statistically inconclusive, is promising 
for the future validation of the Spanish DEMS.  
CONCLUSIONS: The early stages of our research confirm that the Spanish UNC DEMS is an 
easy to use and easy to understand, one-item questionnaire that can improve the management 
and monitoring of Spanish-speaking DED patients. 
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INTRODUCTION 
Dry Eye Disease (DED) is a common, chronic ocular surface disease that diminishes 
quality of life and is poorly managed because symptom severity experienced by patients does 
not correlate well with disease severity found on exam.1-8 We rely on patient symptoms to guide 
management, and that, in turn, demands  well-developed patient-centered questionnaires to 
standardize the reporting of symptoms and the effect on vision related quality of life (VRQOL).9 
Existing instruments, such as the Ocular Surface Disease Index (OSDI) and Impact of Dry Eye 
on Everyday Life (IDEEL), though validated are complex and time consuming, and are therefore 
not very practical for use in the clinic.10-12 Our colleagues created the UNC Dry Eye 
Management Scale (DEMS) in 2013 to address this need (Figure 1). The DEMS is an easy-to-
use, easy-to-interpret single-item visual analog scale that asks patients to rate the severity of 
their dry eye symptoms and their symptoms’ effects on VRQOL on a graded scale (1-10). Initial 
validity and reliability studies found the DEMS and the OSDI (a well validated DED PROM) to be 
highly correlated (Pearson’s correlation coefficient = 0.789, CI = 0.317, 0.948, p-value = 
0.007).10  The hope is that the DEMS can assist both clinicians and patients in the monitoring 
and management of DED in the time-limited clinical setting. 
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BACKGROUND AND SIGNIFICANCE 
Translating PROMs, such as the DEMS, from English to other languages is necessary to 
bring quality patient-centered care to all patients equally, without regard to language or cultural 
barriers.13-14  This is especially important when 21% of the US population (or 60.6 million 
people) speaks a language other than English in the home (as reported by the U.S. Census 
Bureau’s measurement of language use in the US in the year 2011).15 In the US specifically, 
there is a push to have PRO instruments translated to Spanish, the second most used language 
in the country.15-16 However, translating a PROM is not a simple process, nor is it “just a 
translation.” In fact, the literature refers to it as a “cross-cultural adaptation,” because it includes 
both translation of the words of the document, and the cultural context as well,  in an effort to 
maintain equivalence between the original and translated versions.13-14, 16-17 To accomplish 
equivalence, PROM translation guidelines suggest a methodology (sometimes referred to as the 
“universal method”) that includes multiple steps in translation, testing, and reworking before 
releasing the translated instrument for general use (Figure 2).16-17 Moreover, policy makers are 
increasingly interested  in guidelines for PROMs translation as evidenced by the Affordable 
Care Act’s (ACA) establishment of Patient Centered Outcomes Research Institute (PCORI) and 
the United States Food and Drug Administration’s (FDA) institution of new guidelines.16, 18-23 
Regulatory agencies like the FDA and the European Medicines Agency (EMA) have given  
growing attention to “linguistic validation and linguistic equivalence of translated instruments,” 
raising the bar on what they require of evidence claiming linguistic equivalence.16 The primary 
aim of this study was to use best practices to translate the UNC DEMS to Spanish and to 
conduct a feasibility and comprehensibility study of a Spanish-language version of the DEMS 
(henceforth known as the “Spanish DEMS”) in a Spanish-speaking population (Figure 2). A 
secondary aim was to perform initial validity and reliability testing of the Spanish DEMS, alone 
and as it compares to the original English instrument. 
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METHODS 
The Spanish Language Validation Study of the University of North Carolina Dry Eye 
Management Scale (UNC DEMS) consists of two phases – Phase I: translation of the 
instrument, and Phase II: initial comprehensibility and feasibility testing of the instrument via 
cognitive interviewing of Spanish-speaking patients with DED symptoms.  
Phase I: Spanish Translation of the UNC DEMS  
To translate the DEMS, I followed the spirit of the universal method within the scope of 
our study.16 I recruited translators, native bilingual speakers without familiarity with the study, 
each hailing from a different country. One translator performed the “forward translation,” one a 
“back translation,” and the third the last “forward translation.” I then performed a reconciliation 
with the help of an expert translator, a native bilingual speaker from the research team. I 
identified and reconciled discrepancies and possible problems between the translation versions, 
thus creating the Spanish DEMS to be administered in Phase II of the study (Figure 3). I also 
adapted accompanying documents through a more direct translation, and reviewed and edited 
these with the team’s expert translator. These included the Consent Forms and Cognitive 
Interview Script.  
Phase II: Spanish Language Validation  
After I successfully translated the UNC DEMS to Spanish, I was trained in cognitive 
interviewing24-25 and obtained IRB approval from both the UNC and Duke IRBs to conduct the 
study.  I aimed to recruit up to 20 Spanish-speaking patients, based on expert recommendations 
familiar with the process of cognitive interviewing, and as a starting point to compare validity 
and reliability of the Spanish and English versions of the instrument. I ultimately administered 
the Spanish DEMS to 13 Spanish-speaking patients with DED symptoms and subsequently 
performed cognitive interviewing on those patients, all of which took place in Spanish. The 
patients included those with diagnoses of DED and/or pterygium.  I accepted pterygium patients 
for the study because they experience similar symptoms, and there is a large Latino population 
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with pterygia. I strived to select a broad range of subjects in order to include an adequate 
representation of women and men, people of different ages, and people with different severity of 
DED. Patients were generally recruited in the clinic prior to their scheduled ophthalmology 
appointment. This phase took place from May 2014 – June 2014. 
After completing the Spanish DEMS, I asked patients the cognitive interviewing 
questions below to elucidate patients’ understanding of the instrument: 
 
“What do you think the question is asking 
about?” 
“¿Qué piensa que le estoy preguntando 
con este cuestionario?” 
“I asked you to use a 1 to 10 scale. Can 
you describe what you are thinking of 
when you think of a 1? [Pause for patient 
to answer] And what about the 10—what 
are you thinking of? [Pause for patient to 
answer] What about the middle? What are 
you thinking of when you think of the 5?” 
“Le estoy pidiendo utilizar una escala del 
“¿Que significa para usted el numero 1: 
poco o mucho? [Pausa para la 
respuesta]. ¿Y con el 10 – qué  significa? 
[Pausa para la respuesta]. ¿Y en el 
medio? Qué piensa cuando lo califica en 
5?” 
 
“People usually say the symptoms of dry 
eyes are pain, burning, grittiness, ‘feeling 
like something’s in your eye’, tearing, and 
sensitivity of light. I’d like to take each of 
these, and ask what they mean to you. 
First, let’s start with pain. How does pain 
from dry eyes feel to you?” [Repeat 
question for the remaining five 
symptoms] 
 
“Normalmente, la gente dice que los 
síntomas de ojos secos son dolor, ardor, 
lagrimeo, sensación de arena como “si 
tuviera algo dentro del ojo,” y sensibilidad 
a la luz (la luz le ofende). Me gustaría 
repasar cada uno de estos síntomas, y 
preguntarle ¿qué significan para usted? 
Primero, empecemos con dolor. ¿Que tipo 
de dolor siente debido a los ojos secos?” 
[Repite la pregunta para los otros 
síntomas]. 
 
“In the questionnaire, we asked about how 
your dry eye symptoms affected your daily 
life. What does daily life mean to you?” 
 
“En la encuesta, le preguntamos que tanto 
afectan su vida diaria los síntomas de ojos 
secos. ¿Qué significa “vida diaria” para 
usted?” 
 
“When you picked a number on the scale, 
were you thinking more about the dry eye 
symptoms, the effect on your daily life, or 
both?” 
“Cuando eligió un numero en la escala del 
1 al 10, ¿pensó más en los síntomas de 
ojos secos, el efecto en su vida diaria, o en 
ambos?” 
 
“Does this scale let you say how good or 
bad your eyes are feeling?” 
 
“¿Esta escala le permite decir qué mal o 
que bien se sienten sus ojos, si o no?” 
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I recorded patient responses to cognitive interviewing in order to ascertain the 
comprehensibility and ease-of-use of the Spanish language questionnaire, as well as to get the 
patients' general feedback on the instrument and their suggestions for future modifications.  
All patients then received a per usual routine eye examination with the addition of three 
dry eye tests: (1) Schirmer’s Test, (2) Tear Break-Up Time (TBUT), and (3) Oxford Grading 
Scheme for corneoconjunctival fluorescein staining (Oxford Grade). Each patient was also 
assigned a clinician-determined overall dry eye disease severity rating (normal, mild-to-
moderate, or severe). I collected this information for eacy patient for the purpose of validity 
analysis, to be described below.  
Statistical Analysis: 
While qualitative analysis helped me assess feasibility and comprehensibility of the 
Spanish DEMS translation,24 my data analysis was primarily quantitative to assess validity and 
reliability of the Spanish DEMS as it compares to the English instrument. I conducted an 
analysis consistent with the literature and followed those guidelines recommended to assess 
equivalence of translated PROMs.26-30 This analysis is strictly illustrative, as sample size is too 
small for stable data analysis.16  
First, simple descriptive statistics illustrate UNC Spanish DEMS scores, clinical tests 
scores, and clinician reported overall disease severity.  
Second, I evaluated internal validity of the UNC Spanish DEMS by comparing patient-
reported symptom severity and clinical judgment of disease severity withSpearman’s correlation 
coefficient. To do this, I first correlated each patient’s UNC Spanish DEMS score to each of his 
or her three clinical tests. Next, I compared the UNC Spanish DEMS scores to clinician 
judgment of overall disease severity for each patient.  
Third and finally, I assessed external validity by comparing performance on the Spanish 
language DEMS to performance on the English language instrument in two samples of patients 
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of similar disease severity. I used the Mann-Whitney test (Wilcoxon Rank Sum test) to compare 
performance by the entire population samples, and also across disease severity categories.  
 I performed all statistical analysis using Stata 13 software and I considered a p-value < 
0.05 to be statistically significant. 
 
RESULTS 
Phase I: 
 
The translation process of the UNC DEMS to Spanish adhered to the spirit of the 
universal method within the scope of our study.13-14, 16-17 Native bilingual translators who were 
not familiar with the study were recruited to perform forward, back, and forward translations. In 
an effort to avoid colloquialisms and develop a questionnaire that would be applicable 
universally, I recruited translators from a variety of different Latino countries. In addition to 
translating the PROM, I asked them to identify phrases that did not translate well or were 
troubling. I took these notes into consideration when I reviewed the different translations for 
reconciliation, which I performed with the help of an expert translator, a native bilingual speaker 
from the research team.  
To reconcile the translations, I reviewed each version and identified discrepancies and 
potential problems, such as dropped or combined ideas, changes in meaning, added medical 
jargon, and added ideas. A list of the most prominent examples of discrepancies can be seen in 
Table 1.  In addition to identifying these discrepancies, I noted that the language became more 
complicated as the translation process progressed, and the early easy reading level was not 
preserved in subsequent translations. I solved these problems by choosing the simplest version, 
and making the necessary edits to essentially reconcile the two Spanish versions of the DEMS. 
This is consistent with the idea of reconciliation in the universal method, choosing the best 
version to be the base translation, and making the necessary changes. A vital goal of surveys  
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is “comprehensibility,” so with the help of my faculty advisors and translation expert,I made the 
DEMS as easily comprehensible as possible. In this way, and with collaborative help, I created 
the Spanish DEMS (Figure 2) to be used in Phase II of the study. All versions of the DEMS 
Translation Process can be seen in Appendix C, including original in English and final Spanish 
reconciliation.) 
 
Phase II: 
Of the 13 patients recruited, all agreed to participate in the study and completed 
consent.  I also informed them that I was entering them into a lottery from whom a small 
number of patients would be chosen at random to receive $10 gift cards. Basic demographic 
information of the patients interviewed in Phase II is provided in Table 2. There were slightly 
more women (61%) than men (31%), and a broad age range was represented (26-75). It 
should be noted that two patients over the age of 70 years old appeared to have more 
difficulty with cognition in general, and their confusion was not specific to the Spanish DEMS 
or the cognitive interview. All 13 of the participants were Hispanics or Latino; 5 were bilingual 
in Spanish and English, and  8 spoke only Spanish. The sample also included an equal 
distribution of patients with DED (54%) and pterygium (46%). 
In general, patient responses from the cognitive interviewing process indicated that 
patients understood and liked the UNC Spanish DEMS questionnaire.  
Given the need to ensure content validity of the Spanish language instrument, I 
assessed understanding of wording and concepts used throughout the questionnaire, both in 
the body of the instructions and within the scale itself. Subject interview responses suggest 
that patients generally understood, related to, and agreed with the wording of symptoms, the 
term daily life, examples of daily life, and descriptions of grades within the scale. This 
supports the hypothesis that the UNC Spanish DEMS is appropriately translated for the target 
population. 
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Furthermore, subject interview responses indicated patients selected their UNC 
Spanish DEMS number scores based on their synthesis of both severity of symptoms and the 
overall effect of DED on their quality of life, which was the original intention of the scale. 
Patients reported no trouble in remembering symptoms and their effects over the last week, 
indicating that the reference period is appropriate. Patients agreed that the scale allows them 
to say how good or bad their eyes are feeling and express what they need to tell their doctor.  
Subject interview responses also gave rise to potential modifications to be considered 
for future versions of the Spanish DEMS. Two additional symptoms that participants 
mentioned repeatedly can be considered for incorporation.  “Itchiness” (described as 
“comezon” or “picason”) was reported by 5 patients and “redness” (described as “se me 
ponen rojos los ojos”) was reported by 4 patients. An additional example of daily life also 
came to my attention. More than half of the patients mentioned “doing things outside” as an 
activity that should be included in the instructions section of the questionnaire. They 
discussed it in the context of going for a walk, gardening, and construction work, but the 
concept could be incorporated into the survey by a broader term “estar afuera” or “hacer 
actividades/trabajo afuera” (“to be outside” or “to do activities/work outside”). It should be 
noted that these phrases are applicable to both DED and pterygium patients equally (each 
was equally represented in the two subgroups). The UNC DEMS investigative team can 
consider adding these symptoms and daily life examples to a future version the Spanish 
language version of the DEMS.  
Even without any modifications, it is apparent that the UNC Spanish DEMS has been 
accurately and appropriately translated for use in a Spanish-speaking population.  
Statistical Analysis:   
While I relied on open-ended, cognitive interviewing to assess feasibility and 
comprehensibility of the Spanish DEMS translation, my testing of reliability and validity of the 
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Spanish DEMS was more quantitative.  . It must be noted that this analysis is strictly illustrative 
as sample size is too small for stable data analysis.  
First, simple descriptive statistics illustrate the findings. Thirteen subjects completed the 
UNC Spanish DEMS questionnaire, were assessed with three clinical tests (Schirmer’s Test, 
TBUT, and Oxford Grade), and were assigned an overall dry eye disease severity grade by the 
clinician (1= normal, 2= mild-to-moderate, 3= severe). Means, standard deviations, and ranges 
of these variables can be seen in Table 3. Average Spanish DEMS score was 7 (SD 2.16). 
Frequencies of Spanish DEMS scores can be seen in Figure 4. The small sample size makes a 
poorer distribution more likely;; the data are skewed left given that the mean (7) is less than the 
median (8). Average clinical test scores were Oxford Grade 1.10 (SD 1.08), TBUT 5.17 (SD 
2.64), and Schirmer’s Test 19.04 (SD 13.27), corresponding to mild corneal staining, rapid tear 
break-up, and adequate tear production, respectively (Table 3). Frequencies of dry eye disease 
severity categories are shown in Figure 5. Most patients (77%) were classified as having mild-
to-moderate dry eye disease.  
The seemingly moderate disease severity of these patients may be due in part to the 
presence of pterygium patients in the sample. While they have similar DED symptoms, they do 
not have the same findings on exam to signify severity. For example, the average Schirmer’s 
test shows no disease in pterygium, but has a particularly wide standard deviation. This is likely 
because the pterygium patients have a tendency to produce more tears (reaction tearing) rather 
than less tears (as we might expect with DED). Also, TBUT and Oxford Grade are likely to be 
unaffected in pterygium patients. In this way, the presence of pterygium patients in our sample 
may have skewed the disease severity data, but because pterygium is relatively common in 
Latina populations, it is important to determine whether the Spanish DEMS is useful for these 
patients.  
Second, I evaluated internal validity of the Spanish DEMS by comparing patient-reported 
symptom severity and clinical judgment of disease severity by generating Spearman’s 
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correlation coefficients (Table 4). I first compared the Spanish DEMS scores and each of the 
three clinical tests, and found non-significant weak degrees of correlation. Spearman’s 
correlation coefficients for Oxford Grade, TBUT and Schirmer’s Test were 0.247, -0.12, and -
0.234, respectively (all p-values > 0.05). Next, I compared the Spanish DEMS scores and 
clinician-reported overall disease severity ratings. These, too, produced a non-significant weak 
degree of correlation (Spearman’s correlation coefficient = 0.233, p-value > 0.05). This is less 
than the correlation between the UNC English DEMS and clinician-reported disease severity 
(Spearman’s correlation coefficient = 0.532, p-value < 0.05). These relationships can be better 
visualized in the scatter plots with best-fit lines (Figures 6-10).  
The poor correlation between Spanish DEMS scores and disease severity variables was 
expected given the fact that DED symptom severity does not correlate well with disease 
severity.8 This difference may have also been amplified by the presence of pterygium patients in 
our sample, as described above. While the magnitude of these correlations was not strong, the 
direction of the correlations was expected. For example, as disease severity increases, so might 
symptoms and therefore DEMS Scores (Figure 6). Similarly, as Oxford grades increase, they 
denote increase in disease severity, and it makes sense that DEMS scores increase as well 
(Figure 7). On the other hand, Schirmer’s Test and TBUT indicate severe disease with low 
numbers. Therefore, as disease severity increases, these test results decrease, and Spanish 
DEMS scores decrease, as well (Figure 8 and 9).  
The third and final step of my statistical analysis was to assess external validity by 
comparing performance on the Spanish language DEMS to performance on the English 
language instrument in another sample.  I used the Mann-Whitney test (Wilcoxon Rank Sum 
test) to compare performance by the entire population samples, and also across disease 
severity categories (Table 5). For two PROMs to perform similarly, we would expect Mann-
Whitney test to show that the difference between the two is not statistically significant. I found 
this to be the case for the mild-to-moderate and severe disease categories (p>0.05), but not for 
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the normal disease category or the overall population (p<0.05). This may be due to small 
sample size of the pilot, and as described above, pterygium patients may skew the clinical 
measures. Pterygium patients with severe symptoms may be graded as “normal DED status” 
because they do not have the same clinical findings as classic DED patients.  
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CONCLUDING DISCUSSION  
Our colleagues developed the UNC DEMS in an effort to improve the management of 
DED, a chronic, potentially debilitating disease that is poorly managed because of the weak 
correlation between patient-reported symptom severity and clinician-observed disease 
severity.1-9 In the context of a growing need for valid and reliable PROM translations, the 
primary aim of this study was to translate the UNC DEMS to Spanish and to conduct a feasibility 
and comprehensibility study of a Spanish-language version of the DEMS in a Spanish-speaking 
population. 13-14, 16-23 The Spanish UNC DEMS was developed in a cross-cultural adaptation 
method similar to the recommended universal translation methodology and therefore takes into 
account both linguistic and cultural differences.16-17 Cognitive interviewing demonstrated the 
accuracy and appropriateness of the translation24,25 and provided us with additional examples of 
daily life and symptoms that can be considered for addition to a future modified version of the 
Spanish DEMS. The early stages of our research confirm that the Spanish UNC DEMS is an 
easy to use and easy to understand, one-item questionnaire that can be useful in Spanish-
speaking populations to measure DED symptom-severity and how it affects VRQOL. 
A secondary aim of the study was to perform initial validity and reliability testing of the 
UNC Spanish DEMS, alone and as it compares to measurements arising from the original 
English instrument. This analysis was carried out according to recommendations for assessing 
validity, reliability, and essential equivalence between a PROM translation and its original 
version,26-27 and was consistent with examples in the literature on other DED questionnaires 
translated to Spanish.28-30 It must be noted that this analysis is strictly illustrative as sample size 
is too small for stable statistical data analysis (N=13).16 As a test of internal validity, I correlated 
Spanish DEMS scores and measures of disease severity including clinical tests and clinician-
reported overall disease severity. Spearman’s correlation coefficients showed non-significant 
weak degrees of correlation, as expected given the fact that DED symptom severity does not 
correlate well with disease severity.8 While the magnitude of these correlations was not strong, 
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the direction of the correlations was appropriate, and is a promising indication of the validity of 
the instrument. As a test of external validity, I compared performance on the Spanish language 
DEMS to performance on the English language instrument in another sample of English 
speakers using the Mann-Whitney test. While performance on the two language versions was 
not statistically comparable between the overall population or for the normal disease category, it 
was significantly similar in the mild-to-moderate and severe disease categories, which is still 
promising for the equivalence of the two PROMs. This early validity and reliability testing, while 
statistically inconclusive, is promising for the future validation of the Spanish DEMS.  
A sample of 13 participants, although it is too small for complex statistical analysis, is 
more than enough for conclusive qualitative analysis of cognitive interviewing , 24,25 Nonetheless, 
the DEMS team looks forward to further statistical evaluation with a larger sample size in order 
to learn more about the performance of the Spanish DEMS instrument.  
Another consideration for this analysis was the inclusion of patients with pterygium. 
These patients are included in the study because they experience symptoms similar to DED, 
and therefore provide valuable information in the cross-cultural adaptation of the PROM. 
However, they do not have the same findings on exam to signify disease severity, and their 
presence in the sample may skew the disease severity data. I considered repeating the analysis 
without pterygium patient data, but decided against it, since the sample size is already so small 
(n=13), obviating any further subgroup analysis. Another concern is that the inclusion of 
pterygium patients in the sample makes comparison between the Spanish and English versions 
of the instrument more difficult, as disease differences may be associated with other differences 
in the two sample populations. However, with ample future data collection, we will be able to 
extend our comparison of the two instruments and establish equivalence. Ultimately, I feel 
pterygium patients’ inclusion in the study strengthened our work, as there is a strong presence 
of Latinos with pterygium and DED symptoms in our clinic populations.  
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Our translation process was not identical to that of the universal method of PROM 
translation.16,17 I recognize the advantage of using this ideal method, and strove to mimic it as 
closely as possible given the scope of the study and the slim available resources. One early 
shortcoming occurred when I was only able to recruit enough native bilingual speakers to 
perform a single forward, back, and forward translation, rather than multiple independent 
simultaneous translations for each step of the process. However, reproducing the essential 
steps of forward, back, and forward translations, followed by a reconciliation, and pre-testing 
with cognitive debriefing interviews in a sample population before releasing the instrument for 
use in the general public, is the best attempt to cross-culturally adapt the UNC DEMS to 
Spanish I can make at this time.16 Moreover, a review of the literature shows that studies that 
closely mimic the universal translation method can still achieve equivalence with the original 
PROM, even if their methods are not exact (Appendix A).31 The initial success of our translation 
is evident in the cognitive interviewing results, and further testing will elucidate the validity and 
reliability of the instrument.  
Another potential criticism is that the Spanish language OSDI was not administered in 
this initial pilot study of the Spanish DEMS. Literature on its translation validation is not readily 
available, and furthermore, its use has only been studied in Spain, rather than in Central 
American immigrants, who are more likely to be patients at UNC. Furthermore, the Spanish 
OSDI is not freely available to the public, and this study’s resources did not permit us to 
purchase access at this early stage of research. However, a review of the literature has allowed 
for an initial analysis of these results in light of other Spanish language quality of life 
questionnaires.28-30 In line with the validation processes used by other Spanish language QOL 
PROMs, I use data from the English DEMS to illustrate the validity of the Spanish DEMS .25-27, 31-
41  This is particularly appropriate given that the data were collected in the same clinical setting, 
and the physicians and their clinical judgment ought to be roughly the same. In a future, larger 
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study, it would be useful to be able to assess the comparative performance of the Spanish 
DEMS to the Spanish OSDI, but that is beyond the scope of this initial pilot study.  
A final limitation of this study is that it took place in a single clinic, the UNC Kittner Eye 
Center. This was appropriate given the scope of the pilot study and the adequate diversity and 
number of Latino patients willing to participate; however, it may limit the generalizability of the 
Spanish DEMS. Future studies across multiple providers and centers will help in the 
generalizability and development of the questionnaire.  
In conclusion, the early phases of testing indicate that the Spanish DEMS will help meet 
the need for valid and reliable PROM translations for Spanish-speaking dry eye patients. Given 
that it was developed in the spirit of the universal method of cross-cultural adaptation, it is 
linguistically and culturally appropriate, and this pilot test of its comprehensibility shows that  it is 
easy and quick to use in the clinical setting. Future work includes further validation of the UNC 
DEMS Spanish Language instrument, especially in larger samples, across multiple providers 
and centers, and in comparison to the Spanish-language OSDI. Research in the development 
and evaluation of the UNC DEMS is ongoing. The DEMS investigative team is also currently 
testing the responsiveness of the questionnaire by estimating the minimally clinically important 
difference (MCID). Continued research on both the English and Spanish versions of the UNC 
DEMS includes validity and outcomes studies across multiple providers and centers, but the 
UNC DEMS, in both Spanish and English, can help guide the management of DED and 
measure its effect on patients’ quality of life. 
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TABLES 
Table 1. Examples of Problems in Translation 
Example Description of the problem’s effect on translation fidelity 
Burning Was changed to “itching,” and then to a word “picor” that can mean either burning or itching. This could cause confusion for patients. 
Grittiness 
No translation found. Eventually combined with the idea of “feeling like 
something is in your eye”, by adding feeling like “a grain of sand” is in your 
eye. 
Dry Eye “Dry Eye” was later changed to “sequedad ocular”, meaning “ocular dryness.”  Example of introduction of medical jargon. 
Daily Life 
“Daily Life” was translated two ways, first to “vida diaria” and also to “rutina 
diaria.” One directly translates to “daily life” while the other means “daily 
routine.” This was a change in meaning. 
My symptoms are 
mild and easily 
tolerable. 
“Mild” was dropped. 
Final Question 
The final question (“Is there anything else you would like your doctor to 
know about your eyes?”) was made much wordier and complicated (“Is 
there anymore information relevant to your eyes that you would like to 
share with your Doctor and/or medical health care provider?”). 
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Table 2. Patient Demographics 
 
Patient Demographics 
Sex (%) 
     Male (31%) 
     Female (69%) 
Mean Age in Years (range) 
     52.54 (26 – 75) 
 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
 
 
21	  	  
 
 
 
Table 3. Descriptive Statistics  
 
Mean Standard Deviation Range 
DEMS Score 7 2.16 2 - 10 
Clinical Test Scores    
     Oxford Grade 1.10 1.08 0 - 3 
     TBUT 5.17 2.64 2.25 - 10 
     Schirmer’s Test 19.04 13.27 0.5 - 40 
Clinician Reported Disease Severity*  1.92 0.49 1 – 3 
*Clinician Reported Disease Severity (1= Normal, 2= Mild/Moderate, 3= Severe) 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
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Table 4. Relationship (Spearman’s rho) between Spanish DEMS Scores and Measures of 
Disease Severity  
 
Spanish DEMS Score 
Oxford Grade Correlation 0.247 
 P value 0.416 
TBUT Correlation -0.12 
 P value 0.696 
Schirmer’s Test Correlation -0.234 
 P value 0.463 
Disease Severity Correlation 0.233    
 P value 0.443 
 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
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Table 5. Comparing performance on the Spanish and English DEMS 
 Median DEMS Score  
 Spanish English p-value 
Overall Sample 8 5 0.004* 
Dry Eye Disease Severity    
     Normal  7 1.25 0.024* 
     Mild to Moderate  7.5 6 0.123 
     Severe  9 7 0.655 
 
 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
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FIGURES 
Figure 1: English UNC DEMS 
UNC Dry Eye Management Scale  
Instruction:  
Your dry eye symptoms may include: pain, burning, tearing, grittiness, 
“feeling like something is in your eye”, and/or sensitivity to light.  
 
We want to know how bad your dry eye symptoms are and how they affect 
your daily life and the things you want to do like reading, driving, working 
with a computer, watching TV, or doing things you enjoy.  
 
Please circle the number (1-10) that best describes your dry eye 
symptoms and how they affect your daily life over the past week. 
2  3  4  5  6  7  8  9 1 10 
[1 - 2]  
My symptoms 
are not a 
problem.  
 
My dry eye does 
not affect my 
daily life at all.  
[3 - 4] 
My symptoms 
are mild and 
easily tolerable. 
 
My dry eye 
hardly affects my 
daily life.  
[5 - 6] 
My symptoms 
are moderately 
bothersome.   
 
My dry eye 
sometimes 
affects my daily 
life. 
[7 - 8] 
My symptoms are 
very bothersome.   
 
My dry eye 
frequently affects 
my daily life. 
[9 - 10] 
My symptoms 
are severe and I 
need immediate  
medical care.   
 
My dry eye 
greatly affects 
my daily life. 
Is#there#anything#else#you#would#like#your#doctor#to#know#
about#your#eyes?!
Copyright!©!The!University!of!North!Carolina!at!Chapel!Hill,!2013!
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Figure 2: Final UNC Spanish DEMS  
 
 
 
Escala de Manejo de Ojo Seco  
de la UNC  
Instrucción:  
Los síntomas de ojo seco pueden incluir: dolor, ardor, lagrimeo, sensación de 
arena como “si tuviera algo dentro del ojo”, y/o sensibilidad a la luz.  
 
Deseamos saber cuan severos son sus síntomas de ojo seco y cómo le 
pueden afectar su vida diaria y las actividades que desea realizar tales como 
leer, conducir, trabajar con una computadora, ver TV, o hacer tareas que 
disfruta.   
 
Por favor, encierre en un circulo el número (1-10) que mejor describe sus 
síntomas de ojo seco y cómo han afectado su vida diaria en la última semana.  
2  3  4  5  6  7  8  9 1 10 
[1 - 2]  
 
 
Mis síntomas no 
representan un 
problema.  
 
 
 
Mi ojo seco no 
afecta mi vida 
diaria en nada.  
[3 - 4] 
 
 
Mis síntomas son 
leves y fácilmente 
tolerables.  
 
 
 
No es muy común 
que mi ojo seco 
afecta mi vida 
diaria. 
[5 - 6] 
 
 
Mis síntomas 
son 
moderadamente 
molestos. 
 
 
En ocasiones, 
mis ojo seco 
afecta mi vida 
diaria.  
[7 - 8] 
 
 
Mis síntomas 
son muy 
molestos. 
 
 
 
Mi ojo seco 
afecta mi vida 
diaria con 
frecuencia.  
[9 - 10] 
 
 
Mis síntomas 
son severos y 
necesito 
atención médica 
inmediata.  
 
Mi ojo seco 
afecta mi vida 
diaria de forma 
significativa. 
¿Hay%alguna%otra%información%sobre%sus%ojos%que%quiera%
compar8r%con%su%doctor?%!
Copyright!©!The!University!of!North!Carolina!at!Chapel!Hill,!2013!
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Figure 3: Translation Methodology Model16 
 
 
SOURCE:  model  reprinted from Eremenco, S. L., et al. (2005). "A comprehensive method for 
the translation and cross cultural validation of health status questionnaires." Eval Health Prof 
28(2): 212-232. 
 
 
 
27	  	  
Figure 4. Frequency of UNC Spanish DEMS Scores  
  
 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
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Figure 5 . Frequency of Disease Severity Groups  
 
 
 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
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Figure 6. Plot of Spanish DEMS Score vs Dry Eye Disease Severity  
 
 
 
 
 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
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Figure 7. Plot of Spanish DEMS Score vs Oxford Grading Scheme 
 
 
 
 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
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Figure 8. Plot of Spanish DEMS Score vs Schirmer’s Test  
 
 
 
 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
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Figure 9. Plot of Spanish DEMS Score vs Tear Break-Up Time   
 
 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
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Figure 10. Plot of English DEMS Score vs Dry Eye Disease Severity 
 
 
 
 
SOURCE:  original data collected by first author (Spanish DEMS) and data from earlier UNC 
DEMS validation collected by Grubbs, Huynh et al.  
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APPENDIX A:  
A Systematic Review of Literature on Translating PRO Instruments to Spanish 
Such that Validity and Reliability of the Different Instruments are Equal 
 
INTRODUCTION:  
In the last quarter century, health care systems have shifted to focus on patient-
centeredness as a means to better understand health related outcomes and quality of life. 
Patient Reported Outcome Measures (PROMs) are one vehicle for capturing the patient 
perspective, and they are being introduced into nearly all fields of medicine, both in research 
and clinical practice.  
This expanding phenomenon creates a growing need to be able to translate PRO 
instruments into various languages. As the amount of “multinational and multicultural” research 
studies grows, so does the need to be able to convert an instrument into other languages and 
styles applicable to the relevant countries and cultures1, 2. This matters not just for being able to 
do cross-national research, but also for being able to create cross-national health care quality 
improvements3.  
As one might expect, the need for properly translated PROMs exists within the United 
States, and not just across national borders. Researchers need to include non-English speakers 
and immigrants in their work in order to avoid bias in the measurement of quality of health or 
health care use1, 2. Excluding an important population because of a lack of measurement 
instrument can be avoided if quality translations are performed. Finally, translations of PROMs 
are necessary in clinical practice so that physicians and health care providers can bring quality 
patient-centered care to all patients equally, without limitation due to language differences and 
cultural barriers2. This is especially important when 21% of the US population (or 60.6 million 
people) speaks a language other than English in the home (As reported by the U.S. Census 
Bureau regarding Language use in the US in the year 2011) 4. In the US specifically, there is a 
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push to have PRO instruments translated to Spanish, the second most used language in the 
country3, 4.  
However, translating a PROM is not a simple process, nor is it “just a translation.” In fact, 
the literature refers to it as a “cross-cultural adaptation,” because it includes translation of the 
words of the document, and the cultural context in an effort to maintain equivalence between the 
original and translated versions1-3, 5. To accomplish equivalence, PROM translation guidelines 
include multiple steps in translation, testing, and reworking before releasing it for general use3, 5. 
Regulatory agencies like the United States Food and Drug Administration and the European 
Medicines Agency have expressed a growing interest in “linguistic validation and linguistic 
equivalence of translated instruments,” so they have raised the bar on what they require of 
evidence claiming linguistic equivalence3.  
As we can see, the need for valid and reliable PROM translations spans many settings, 
as they are desirable in global, domestic, research, and clinical realms. With this increasing 
interest in and need for valid and reliable PROM translations and in light of the development and 
validation of the UNC Spanish DEMS, I performed a systematic review to determine what needs 
to be done with regards to translating a PROM into Spanish, such that validity and reliability of 
the different instruments are equal.  
METHODS:  
The main objective of this systematic review was to determine what needs to be done 
with regards to translating a PROM into Spanish, such that validity and reliability of the different 
instruments are equal. To answer this question, I performed a PubMed search on March 24, 
2014, using the query (results provided in parentheses) “quality of life AND translation AND 
Spanish” (186 articles). The search was filtered for “free (full) text available” and “abstract 
available” (59 articles), and finally for being written in English (42 articles). These 42 articles 
were subsequently pulled into a research database for full title and abstract review. For articles 
to be included in the final analysis, the articles had to discuss the methods for translating a 
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specific PROM from English to Spanish and include analysis of validity and reliability, 
specifically comparing the final PROM to the source instrument. In addition, the PROM being 
studied needed to be relevant to adults (pediatric PROMs were excluded). Of the 42 articles 
undergoing full title and abstract review, 15 articles were eliminated, as they did not meet 
eligibility criteria. 
The remaining 27 articles underwent full-text review. During this phase, I eliminated 3 
articles because the free full text was not available online6-8. I eliminated 3 articles because 
they did not discuss adaptation of an English PROM to Spanish 9-11. I also eliminated 10 
articles because they did not discuss methods of translation and/or analysis comparing the 
new PROM to the original12-21. The remaining 11 articles provided the basis for this review22-32. 
Finally, I surveyed the references of these articles to find additional background information on 
the cross-cultural adaptation of PROMs. This led to further exploration online in search of 
guidelines for the processes of translating and assessing the validity and reliability of health 
related quality of life (HRQOL) PROMs33-35.  
RESULTS: 
Based on this review of the literature, I found 11 studies22-32 that discuss the adaption of 
an English language PROM to Spanish, as well as a handful of articles on guidelines for the 
processes of translating PROMs and assessing their validity and reliability. As such, this report 
will first focus on translation procedures and assessment methodology as a means of giving 
some background before assessing the aforementioned studies as examples.  
Translation Methods 
Today, different organizations and groups of researchers have published guidelines for 
the best way to adapt PROMs to cross-cultural applications1-3, 5, 33, 35. While these guidelines 
differ slightly depending on the organization and the type of PRO they work on, they are still 
quite similar. First, they all strive to achieve equivalence between the PRO instrument in the 
original source language and the subsequent target language. A few types of equivalence 
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included in most guidelines are semantic, idiomatic, experiential and conceptual equivalence1, 2. 
Some guidelines recommend in-depth consideration of these equivalencies before performing 
the translation5, while others focus on it in a later analysis stage of the adaptation1, 2.  
In general, the accepted methodology (sometimes referred to as the “universal method”) 
for translation of PROMs includes the following stages: initial translation (performed 
simultaneously but independently by bilingual speakers), reconciliation (at times by the 
translators and at times by committees), back-translations (again performed by bilingual 
speakers), reconciliation into a final instrument (generally by a committee), and testing of this 
instrument in a sample population (followed by modifications if necessary) prior to final 
publication and implementation1-3, 5.  
The testing done in this last stage is referred to as “pre-testing,” and serves primarily to 
test content validity, but not construct validity, reliability, or item response patterns1. It can also 
help identify translation reversals and errors3. In this way, the pre-testing stage allows for a dry 
run of the new instrument in a representative sample population in order to work out the kinks 
prior to finalization and release to the public for general use. It is also preferable that after the 
translated PROM has been finalized, a larger study follows to allow for further analysis of 
validity and reliability with a larger sample size3.  
Finally, most guidelines recommend every stage of this process be documented in a 
written report1-3, 5. This is important for the team of developers, and also for submission to 
regulatory agencies. They also help further research in the field. Without such reports, it is 
unclear how a translation was performed, and by default it is usually assumed it was not a 
thorough process. A written report ensures transparency of methods and clear documentation.  
Analysis Methods 
Once a PROM is translated, how do we know it is equivalent to the original version? 
How do we know that the translation was successful? The scholarly community agrees that 
formal testing is required to answer these questions, but the specifics are not straightforward. 
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As Anderson points out, “It is difficult if not impossible to make definitive statements about 
cross-cultural equivalence of measures”33. While specific analysis needs may differ from one 
PROM translation to the next, a few things are generally agreed upon. First, we must look at the 
translation method itself; it should be extensive and include testing in a sample to identify errors 
and discuss semantics33. Subsequently, we must perform formal qualitative and quantitative 
analysis to fully answer these questions of equivalence3, 33.  
Qualitative testing includes two methods: (1) “retrospective debriefing interviews” where 
after completing the questionnaire, the patient answers questions about whether items were 
difficult to understand etc. (2) or alternatively “cognitive debriefing interviews” that ask the 
patient questions on an “item-by-item” basis. The former is a much shorter process, but risks 
missing misunderstood items that the patient believed they understood. The later is much more 
thorough, but time consuming3, 34. 
Recommendations for quantitative testing are not consistent across all translation 
guidelines, as they need to be tailored to each specific instrument33. Generally speaking, there 
are two methods that should be employed, one following the other as sufficient data is collected. 
The first method, “classical test theory (CTT),” should be used to assess internal consistency as 
a measure of reliability3, 35. CTT can be implemented during pilot studies because it only 
requires a sample size of 15-30 participants3, and therefore can give us a lot of information 
before we have tested the instrument in a larger group. The analysis comprises basic 
descriptive statistics including means, standard deviations, range of responses, and Cronbach’s 
coefficient alpha to test internal consistency of items within the group (item-subscale correlation 
or item-total correlation)3, 35. It is generally recognized in this setting that Cronbach’s alpha 
values above 0.7 are acceptable, and below 0.2 signify error in translation for a given item 
within a subscale3, 35. While it is important to look at data within the new scale to see if it 
performed appropriately, it is also necessary to look at it in comparison to the original PROM to 
assess equivalence between the two versions. Finally, the data can also be compared to 
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correlations from another instrument previously published or otherwise attainable3. In this way, 
CTT allows us to assess the translated PROM during the preliminary stages of research. Even 
with a small sample size we can learn a lot about a translated PROM and how it functions alone, 
in comparison to the original instrument, and in comparison to other existing instruments.  
The second method, “item response theory (IRT),” is a measure of validity that should be 
used later in research once the sample size has reached at least 200 participants3. IRT allows 
us to analyze differential item functioning (DIF) so that we can compare items between the 
different language versions of the instrument3, 35. We may identify items with measurement bias 
that threaten the instrument’s validity. If one such item is found, the analysis can be run again 
without that item. If the difference is significant without it, the item needs to be excluded from 
future analyses; if not, it can safely be retained3. In this way, IRT analysis should be used once 
proper sample size is reached in order to assess translation equivalence and validity3, 35.  
Examples: Cases from the Literature 
In this review, I found 11 relevant studies22-32 that discussed adapting an English 
language PROM to Spanish and testing it for equivalence, specifically against the original 
version. The PROMs discussed in these articles span a variety of medical fields. Of the 11 
studies, 9 took place in Spain22-30, while the other 2 were performed in the United States 
(California31 and Puerto Rico32). I evaluated the studies on their translation methods, analysis 
methods, and resulting equivalence between the Spanish translation and the English original.  
Assessing Translation Methods 
Regarding translation methodology, I assigned the articles to two groups: those that 
were consistent with universal methods (as laid out above), and those that were not. Of the 11 
studies, 7 used universal methods to translate the PROM from English to Spanish22-25, 27, 31-32. I 
will review the remaining 4 here26, 28-30.  
Three used translation procedures that were similar to, but not fully consistent with the 
universal method26, 29-30. One lacked the patient-input component, such as cognitive debriefing 
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interviews or focus groups following questionnaire administration in the pre-testing phase26. The 
second was not clear in reporting if questionnaire feedback came from patients or clinicians 
(referred to as “local users”)30. The third mimicked the forward and back-translation method, but 
rather than having simultaneous independent forward translations created by native bilingual 
speakers, they only performed one forward translation and it was created by a group of Spanish 
doctors with varying levels of English fluency29.  
The last study used a very different translation method altogether28. They used what is 
called the “dual-panel approach,” where a bilingual panel and a lay panel work together. First 
the bilingual panel creates the translation, later submitting it to the lay panel for consideration to 
“ensure the content is expressed in clear, every day language”28.  
Assessing Analysis Methods 
Regarding analysis methodology, I broke the articles into two groups: those that 
completed the appropriate analysis testing (as outlined above) 22-28, 31-32 and those that did not. 
Of the 11 studies, only 2 did not follow the aforementioned analyses29, 30. One had a very 
thorough analysis but neglected to clearly compare results between the translated PROM and 
the original instrument29. The last study did not use any statistical analysis, instead they only 
used “comprehension rates” to assess equivalence between the different versions of the 
PROM30.  
Assessing Equivalence  
Taking into account the studies’ methods of translation and analysis, as well as the 
numeric results of those analyses, I ultimately assessed the equivalence between the translated 
PROMs and their corresponding source instruments. Of the 11 studies, there were 7 with 
acceptable methods of translation and analysis22-25, 27, 31-32. All 7 of these ultimately showed good 
correspondence between data from the original English PROM and the Spanish translation. I 
will review the remaining 4 studies in more detail26, 28-30.  
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The first was the study that did not include a patient-input component during the 
translation process, but still had thorough analysis26. Even so, it appears to have good 
equivalence when comparing the data from the two versions of the PROM. In this instance, 
equivalence seems to have been maintained without patient contribution during the translation 
process.  
The second study was the one that used the dual panel approach for translation28. It 
also had a very thorough analysis, but produced weak results. The Cronbach’s alpha 
coefficients were similar between the two versions (Spanish = 0.84-0.93, English = 0.85-0.92), 
but none of the other analyses confirmed equivalency. The authors attribute this to a small 
Spanish-speaking sample size (Spanish n=24, English n=148), but there is no way of knowing 
if the translation methods were also a factor until we have more data from a larger sample.  
The third study to review is the one where a group of Spanish doctors jointly created the 
forward translation29. This is the same study where they performed thorough analysis except 
that they did not clearly compare results between the Spanish and the English versions of the 
PROM. While the authors state that the results from the two are similar, they do not quote any 
numbers as hard evidence. They may have completed a successful cross-cultural adaptation 
that is truly equivalent to the original, but the reader cannot be sure if the data from both 
versions are not clearly reported.  
The last study to review is the one whose translation method was nearly consistent with 
the universal method except that it was not clear who provided feedback in the last step (“local 
users” could mean clinicians or patients)30.  This is also the study whose analysis was limited 
to comprehension rates rather than statistical analysis to compare different language versions 
of the PROM. From this information, all we know is that both questionnaires were completed by 
sample populations that did not identify any confusing items. This is not enough to say that two 
PROMs are equivalent, thus illustrating the point that we need thorough statistical analysis to 
prove equivalence.  
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CONCLUSIONS: 
I performed a systematic review to determine what needs to be done with regards to 
translating a PROM into Spanish, such that validity and reliability of the different instruments are 
equal. As a result, this review provides a brief summary of the methods for translating a PROM 
to a second language, statistically analyzing the validity and reliability of the translated 
instrument, and assessing its overall equivalence with the original source PROM.  
To summarize, the current methodology for translating PROMs is described as the 
universal method. It aims for equivalence between the original source PROM and the 
subsequent target PROMs. Various guidelines exist, but most of them agree upon these stages: 
(1) forward translations, (2) reconciliation, (3) back-translations, (4) reconciliation into a final 
translation (5) pre-testing in a sample population (and modification where necessary). Further 
testing should be continued in a larger population.  Formal qualitative analysis (in the form of 
retrospective debriefing interviews or cognitive debriefing interviews) and quantitative analysis 
(as CTT in early stages and as IRT later on) are recommended analyses in addition to other 
statistical tests necessitated by the specific situation. It is important to remember that statistical 
results from the translated and the original PROM must be compared in order to assess the 
instruments’ equivalence. Lastly, the entire translation and analysis processes should be clearly 
and thoroughly documented.  
The original 11 articles that formed the basis of this review serve as examples of studies 
where we can see these methods of translation and analysis put to use. The 7 studies that used 
the universal method of translation and adequate statistical analysis (including transparent 
comparison to the original version) produced PROM translations that are acceptably equivalent 
to their original counterparts. On the other hand, the 4 studies that used other translation 
methods and/or less thorough methods of analysis did not consistently produce equal 
instruments.  This shows that at present, the universal method of translating a PROM is one to 
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strive for, and should be accompanied by adequate analysis, including direct comparison 
between the translated and the original PROMs in order to establish equivalent instruments.  
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APPENDIX B: Cognitive Interviewing Protocol and Template 
 
Cognitive Interviewing Protocol Summary 
 
In brief, I reviewed the clinic schedule for the cornea clinic and resident clinics at the 
UNC Kittner Eye Center for potential Spanish-speaking patients with dry eye disease and dry 
eye symptoms from May 2014 – June 2014. I subsequently recruited these patients in clinic, 
explained the research study, answered any questions, and then had the patients sign informed 
consent documents. I then administered the Spanish DEMS to the participants. After they had 
completed the questionnaires, I then asked the patients multiple questions about the Spanish 
DEMS using the process of cognitive interviewing. This entire process took place in Spanish. 
The basic template for my cognitive interviews is provided on the next page, both in English and 
in Spanish. I asked each patient all the questions in this template and would sometimes ask 
additional questions to clarify a patient response or to gather more relevant information. On 
average, the interviews lasted 20-30 minutes. The project was approved by UNC’s IRB (study 
number 12-2089, reference number 129960). 
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Cognitive Interviewing Template: English Version 
 
 
Did patient take the DEMS before this interview?   YES   NO  
If not please explain: 
 
 
Scripted Introduction: Hello, my name is __________, and I am a medical student helping to 
develop a new questionnaire for dry eyes, specifically for Latino Spanish-speaking patients. If 
you don’t mind, I’m going to ask you a few questions about that questionnaire [show them the 
questionnaire they just completed]. I did not develop this questionnaire, and you are not going to 
hurt my feelings at all with anything you say about it. We want to make this questionnaire the 
best it can be for helping people like you, so feel free to say anything that comes to mind when 
answering my questions. Do you have any questions? Let’s get started.  
 
1. What do you think the question is asking about? 
 
2. I asked you to use a 1 to 10 scale. 
a. Can you describe what you are thinking of when you think of a 1? 
b. And what about the 10—what are you thinking of? 
c. What about the middle? What are you thinking of when you think of the 5? 
 
3. People usually say the symptoms of dry eyes are pain, burning, grittiness, “feeling like 
something’s in your eye”, tearing, and sensitivity of light. I’d like to take each of these, 
and ask what they mean to you?  
a. First, let’s start with pain. How does pain from dry eyes feel to you? 
b. Next, let’s talk about burning. How does burning from dry eyes feel to you? 
c. How about tearing? How does tearing caused by dry eyes feel to you? 
d. Ok, now “feeling like something’s in your eye”. What does “feeling like 
something’s in your eye” caused by dry eyes feel like to you? 
e. Now our last symptom—sensitivity to light. How does sensitivity to light caused 
by dry eyes feel to you? 
f. Do you experience any other symptoms from dry eyes? _____________ How 
does __(previous answer)__ feel to you? 
 
 
4. In the questionnaire, we asked about how your dry eye symptoms affected your daily life. 
What does daily life mean to you? 
a. Follow-up: Can you give me an example of daily life? [NOTE: Interviewer, do 
NOT provide them an example; if they ask for one, say “anything that came to 
mind when I asked the question”] 
 
 
5. When you picked a number on the scale, were you thinking more about the dry eye 
symptoms, the effect on your daily life, or both? 
a. Follow-up: When you say __(previous answer)__, tell me what comes to mind. 
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6. How do your dry eye symptoms affect your daily life? 
 
7. We gave you some examples of daily living. Are there any other examples you can think 
of that we should include in this questionnaire?” 
 
8. We used the words “mild” “moderately” and “severe” to describe your dry eye symptoms. 
a. Do you feel the word “mild” matches a 3-4 on the scale? 
b. Do you feel the word “moderately” matches a 5-6 on the scale? 
c. Do you feel the word “very bothersome” matches a 7-8 on the scale? 
  
9. Similarly, we used the words “hardly” “sometimes” and “frequently” to describe how the 
symptoms may have affected your daily life. 
a. When the scale says “hardly affects your daily life” does that match a 3-4 on the 
scale? 
b. When the scale says “sometimes affects your daily life” does that match a 5-6 on 
the scale? 
c. When the scale says “frequently affects your daily life” does that match a 7-8 on 
the scale? 
 
10. Does this scale let you say how good or bad your eyes are feeling? 
 
11. How easy or hard is it to remember how your dry eyes affected you in the past week? 
a. Follow-up: How do you remember this? 
 
12.  Is there anything else we’ve forgotten or that you think we need to know to make this a 
good scale in describing your dry eye symptoms and the effect on your daily life? 
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Cognitive Interviewing Template: Spanish Version 
 
¿Antes de entrevistar, completó el paciente el DEMS?  SI  NO   
En caso de no, por favor, explique:  
 
 
Scripted Introduction: Hola, me llamo __________, y soy una estudiante de medicina y estoy 
ayudando a desarrollar un nuevo cuestionario para ojos secos, específicamente para Latinos y 
pacientes quienes hablan Español. Si usted acepta, voy a hacerle unas preguntas sobre la 
encuesta [Mostrar la encuesta que acaban de terminar]. Yo no hice el cuestionario y usted 
puede expresar abiertamente sus pensamientos y nosotros apreciamos su colaboración. 
Queremos hacer esta encuesta lo mejor posible para ayudar a gente como usted, entonces, 
con confianza diga cualquier cosa que se le ocurra al responder a mis preguntas. ¿Tiene 
alguna duda? Empecemos.  
 
1. ¿Qué piensa que le estoy preguntando con este cuestionario?  
 
2. Le estoy pidiendo utilizar una escala del 1 a 10.  
a. ¿Que significa para usted el numero 1: poco o mucho?  
b. ¿Y con el 10 – qué  significa?  
c. ¿Y en el medio? Qué piensa cuando lo califica en 5?  
 
3. Normalmente, la gente dice que los síntomas de ojos secos son dolor, ardor, lagrimeo, 
sensación de arena como “si tuviera algo dentro del ojo,” y sensibilidad a la luz (la luz le 
ofende). Me gustaría repasar cada uno de estos síntomas, y preguntarle ¿qué significan 
para usted? 
a. Primero, empecemos con dolor. ¿Que tipo de dolor siente debido a los ojos 
secos? 
b. Ahora, hablemos de ardor. ¿Cómo siente el ardor de ojos secos? 
c. ¿Y acerca del lagrimeo? ¿Cómo siente el lagrimeo causado por ojos secos? 
d. Ok, y ahora, ,”¿Cómo se siente la sensación de arena como “si tuviera algo 
dentro del ojo” que es causada por ojos secos? 
e. Finalmente, nuestro último síntoma - sensibilidad a la luz (sentir que la luz le 
ofende) ¿Que tan severa es la sensibilidad a la luz causada por ojos secos?   
f. ¿Usted sufre de algún otro síntoma de ojos secos? ____________ ¿Cómo se 
siente _____(respuesta previa) _____? 
 
4. En la encuesta, le preguntamos que tanto afectan su vida diaria los síntomas de ojos 
secos. ¿Qué significa “vida diaria” para usted? 
a. Seguimiento: Puede darme un ejemplo de la vida diaria? [NOTE: Interviewer, do 
NOT provide them an example; if they ask for one, say “cualquier cosa en que 
pensó cuando le hice la pregunta.”].  
 
5. Cuando eligió un numero en la escala del 1 al 10, ¿pensó más en los síntomas de ojos 
secos, el efecto en su vida diaria, o en ambos? 
a. Seguimiento: Cuando dice __(respuesta previa)__, dígame en que piensa.  
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6. ¿Cómo afectan su vida diaria sus síntomas de ojos secos?  
 
7. Presentamos unos ejemplos de la vida diaria. ¿Hay otros ejemplos que se le ocurre que 
debemos incluir en la encuesta? 
 
8. Usemos las frases “leves y fácilmente tolerables” “moderadamente molestosos” y “muy 
molestosos” para describir sus síntomas de ojos secos.  
a. ¿Siente que la frase “leves y fácilmente tolerables” coincide con los números 3-4 
en el escala? 
b. ¿Siente que la frase “moderadamente molestosos” coincide con los números 5-6 
en el escala? 
c. ¿Siente que la frase “muy molestosos” coincide con los números 7-8 en el 
escala?  
 
9. Del mismo modo, usamos “no es muy común” “en ocasiones” y “con frecuencia” para 
describir cómo los síntomas han afectado su vida diaria.  
a. ¿Cuándo la escala dice “No es muy común que mi ojo seco afecta mi vida diaria” 
coincide con los números 3-4 en la escala?  
b. ¿Cuándo la escala dice “En ocasiones, mi ojo seco afecta mi vida diaria” 
coincide con los números 5-6 en la escala?  
c. ¿Cuándo la escala dice “Mi ojo seco afecta mi vida diaria con frecuencia” 
coincide con los números 7-8 en la escala?  
 
10.  ¿Esta escala le permite decir qué mal o que bien se sienten sus ojos, si o no?  
 
11. ¿Qué difícil o fácil es recordar que tanto los ojos secos le afectaron la semana pasada?  
a. ¿Cómo logra recordarlo? 
 
12. ¿Hay alguna cosa que se nos haya olvidado o que piense es necesario para hacer esta 
escala útil para describir los síntomas de ojos secos y el efecto en su vida diaria? 
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Appendix C: DEMS Translation Progression 
Figure 1. The Original: The UNC DEMS  
 
Note: The faces were removed during translation due to formatting technicalities. They were 
reinserted for the final Spanish DEMS.  
 
UNC Dry Eye Management Scale  
Instruction:  
Your dry eye symptoms may include: pain, burning, tearing, grittiness, 
“feeling like something is in your eye”, and/or sensitivity to light.  
 
We want to know how bad your dry eye symptoms are and how they affect 
your daily life and the things you want to do like reading, driving, working 
with a computer, watching TV, or doing things you enjoy.  
 
Please circle the number (1-10) that best describes your dry eye 
symptoms and how they affect your daily life over the past week. 
2  3  4  5  6  7  8  9 1 10 
[1 - 2]  
My symptoms 
are not a 
problem.  
 
My dry eye does 
not affect my 
daily life at all.  
[3 - 4] 
My symptoms 
are mild and 
easily tolerable. 
 
My dry eye 
hardly affects my 
daily life.  
[5 - 6] 
My symptoms 
are moderately 
bothersome.   
 
My dry eye 
sometimes 
affects my daily 
life. 
[7 - 8] 
My symptoms are 
very bothersome.   
 
My dry eye 
frequently affects 
my daily life. 
[9 - 10] 
My symptoms 
are severe and I 
need immediate  
medical care.   
 
My dry eye 
greatly affects 
my daily life. 
Is#there#anything#else#you#would#like#your#doctor#to#know#
about#your#eyes?!
Copyright!©!The!University!of!North!Carolina!at!Chapel!Hill,!2013!
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Figure 2. First Forward Translation 
 
 
 
 
 
Escala de Manejo de Ojo Seco  
de la UNC  
Instrucción:  
Los síntomas de ojo seco pueden incluir  dolor, ardor, lagrimeo, sensación de 
arena como “si tuviera algo dentro del ojo”, y/o sensibilidad a la luz.  
 
Deseamos saber cuan severos son sus síntomas de ojo seco y cómo le 
pueden afectar su vida diaria y las actividades que desea realizar tales como 
leer, conducir, trabajar con una computadora, ver TV, o hacer tareas que 
disfruta.   
 
Favor de trazar un círculo alrededor del número (1-10) que mejor describe sus 
síntomas de ojo seco y cómo han afectado su vida diaria en la última semana.  
2  3  4  5  6  7  8  9 1 10 
[1 - 2]  
Mis síntomas no 
representan un 
problema.  
 
Mi ojo seco no 
afecta mi vida 
diaria en nada.  
[3 - 4] 
Mis síntomas 
son leves y 
facilmente 
tolerables.  
 
Mi ojo seco 
difícilmente 
afecta mi vida 
diaria. 
[5 - 6] 
Mis síntomas 
son 
moderadamente 
molestos. 
 
Mis ojo seco 
algunas veces 
afecta mi vida 
diaria.  
[7 - 8] 
Mis síntomas son 
muy molestos..   
 
Mi ojo seco afecta 
mi vida diaria 
frecuentemente. 
[9 - 10] 
Mis síntomas 
son severos y 
necesito cuidado 
médico de 
inmediato. re.   
 
Mi ojo seco 
afecta de forma 
significativa mi 
vida diaria.  
¿Hay%alguna%otra%información%sobre%sus%ojos%que%quiera%
compar8r%con%su%doctor?%!
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Figure 3. Back Translation 
 
 
 
 
 
The UNC Dry Eye Management Scale   
Instructions:   
Dry eye symptoms can include pain, itchiness, tearing, sensitivity to light, and a 
sensation similar to a lodged grain of sand.  
 
We would like to know how severe your dry eye symptoms are and how they 
can affect your daily life and the activities you wish to partake such as reading, 
driving, working with a computer, watching TV, or during other hobbies.  
 
Please circle the number (1-10) that best describes your dry eye symptoms and 
how it they have affected your daily routine in the past week.  
2  3  4  5  6  7  8  9 1 10 
[1 - 2]  
My symptoms do 
not cause any 
trouble.  
 
My dry eyes do 
not affect my 
daily routine.  
[3 - 4] 
My symptoms 
are tolerable.  
 
It is unusual that 
my dry eyes 
affect my daily 
routine.  
[5 - 6] 
My symptoms 
are moderately 
bothersome.  
 
Occasionally, my 
dry eyes affect 
my daily routine.  
[7 - 8] 
My symptoms are 
very bothersome.  
 
My dry eyes 
frequently affect 
my daily routine.  
[9 - 10] 
My symptoms 
are severe and I 
require 
immediate 
medical 
attention.  
 
My dry eyes 
significantly 
affect my daily 
routine.  
Is#there#anymore#informa/on#relevant#to#your#eyes#that#you#
would#like#to#share#with#your#Doctor#and/or#medical#health#
care#provider?#?#!
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Figure 4. Second Forward Translation 
 
 
 
 
 
Escala de Evaluación de Sequedad Ocular de 
UNC 
Instrucciones:   
Síntomas de sequedad ocular pueden incluir dolor, picor, lagrimeo, sensibilidad 
a la luz, y sensación similar a tener un grano de arena.  
 
Nos gustaría saber cómo de severos son sus síntomas de sequedad ocular y 
cómo le afectan en su vida diaria, así como en las actividades en las que le 
gustaría participar (leer, conducir, trabajar en la computadora, ver la televisión, 
u otros hobbies).  
 
Por favor, dibuje un círculo en el número (1-10) que describe mejor sus 
síntomas de sequedad ocular y cómo le afectaron en su rutina diaria la 
semana pasada.  
2  3  4  5  6  7  8  9 1 10 
[1 - 2]  
Mis síntomas no 
me causan 
problemas.  
 
Mi sequedad 
ocular no afecta 
mi vida diaria. 
[3 - 4] 
Mis síntomas 
son tolerables 
 
No es muy 
común que mi 
sequedad ocular 
afecte mi vida 
diaria.  
[5 - 6] 
Tengo síntomas 
moderadamente 
molestos.  
 
En ocasiones, mi 
sequedad ocular 
afecta mi vida 
diaria.  
[7 - 8] 
Mis síntomas soy 
muy molestos.  
 
Mi sequedad 
ocular afecta mi 
vida diaria con 
frecuencia.  
[9 - 10] 
Mis síntomas 
son muy severos 
y necesito 
atención médica 
inmediata.  
 
Mi sequedad 
ocular afecta mi 
vida diaria de 
forma 
significativa. 
¿Hay%alguna%otra%información%relevante%sobre%sus%ojos%que%le%
gustaría%compar:r%con%su%médico%o%proveedor%de%atención%
médica?%!
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Figure 5. Reconciliation: The Spanish DEMS 
 
  
 
 
Escala de Manejo de Ojo Seco  
de la UNC  
Instrucción:  
Los síntomas de ojo seco pueden incluir: dolor, ardor, lagrimeo, sensación de 
arena como “si tuviera algo dentro del ojo”, y/o sensibilidad a la luz.  
 
Deseamos saber cuan severos son sus síntomas de ojo seco y cómo le 
pueden afectar su vida diaria y las actividades que desea realizar tales como 
leer, conducir, trabajar con una computadora, ver TV, o hacer tareas que 
disfruta.   
 
Por favor, encierre en un circulo el número (1-10) que mejor describe sus 
síntomas de ojo seco y cómo han afectado su vida diaria en la última semana.  
2  3  4  5  6  7  8  9 1 10 
[1 - 2]  
 
 
Mis síntomas no 
representan un 
problema.  
 
 
 
Mi ojo seco no 
afecta mi vida 
diaria en nada.  
[3 - 4] 
 
 
Mis síntomas son 
leves y fácilmente 
tolerables.  
 
 
 
No es muy común 
que mi ojo seco 
afecta mi vida 
diaria. 
[5 - 6] 
 
 
Mis síntomas 
son 
moderadamente 
molestos. 
 
 
En ocasiones, 
mis ojo seco 
afecta mi vida 
diaria.  
[7 - 8] 
 
 
Mis síntomas 
son muy 
molestos. 
 
 
 
Mi ojo seco 
afecta mi vida 
diaria con 
frecuencia.  
[9 - 10] 
 
 
Mis síntomas 
son severos y 
necesito 
atención médica 
inmediata.  
 
Mi ojo seco 
afecta mi vida 
diaria de forma 
significativa. 
¿Hay%alguna%otra%información%sobre%sus%ojos%que%quiera%
compar8r%con%su%doctor?%!
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